HomePTX • ASX
add
Prescient Therapeutics Ltd
Nakaraang pagsara
$0.051
Sakop ng araw
$0.048 - $0.052
Sakop ng taon
$0.037 - $0.063
Market cap
37.88M AUD
Average na Volume
728.16K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 624.21K | -35.64% |
Gastos sa pagpapatakbo | 1.93M | -34.84% |
Net na kita | -1.22M | 32.33% |
Net profit margin | -196.17 | -5.13% |
Kita sa bawat share | — | — |
EBITDA | -1.31M | 34.45% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 8.41M | -54.41% |
Kabuuang asset | 16.58M | -33.04% |
Kabuuang sagutin | 934.79K | -56.56% |
Kabuuang equity | 15.65M | — |
Natitirang share | 805.32M | — |
Presyo para makapag-book | 2.55 | — |
Return on assets | -19.69% | — |
Return on capital | -20.82% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.22M | 32.33% |
Cash mula sa mga operasyon | -2.89M | -66.14% |
Cash mula sa pag-invest | 1.00M | -50.00% |
Cash mula sa financing | -148.11K | -1,732.02% |
Net change in cash | -2.05M | -885.92% |
Malayang cash flow | -805.50K | 31.59% |
Tungkol
Prescient Therapeutics Ltd is a clinical stage oncology company. The company is focused on the development of a universal CAR-T platform, enhanced CAR-T cell manufacturing & function and on two small molecule drug targeted therapies. Wikipedia
Itinatag
May 22, 1986
Website
Mga Empleyado
3
